Clinical Trial Update: FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing FLOMAX (tamsulosin) to placebo in men with acute urinary retention related to benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Flomax (tamsulosin hydrochloride)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostate Hyperplasia | Phase 2 | Status: COMPLETED